{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-077591","form_type":"8-K","ticker":"APUS","cik":"0001894525","company_name":"Apimeds Pharmaceuticals US, Inc.","filed_at":"2026-07-13T20:30:43+00:00","discovered_at":"2026-07-13T20:32:00.360018+00:00","generated_at":"2026-07-13T20:32:10.109497+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Apimeds Pharmaceuticals announces 1-for-10 reverse stock split effective July 24, 2026","bullets":["Reverse stock split at 1-for-10 ratio, effective 12:01 a.m. ET on July 24, 2026.","Stock will trade on NYSE American under symbol APUS on split-adjusted basis from July 24.","New CUSIP number for post-split common stock is 03771D201.","Previously expected effective date of March 26, 2026, was delayed; now set for July 24, 2026.","Every ten pre-split shares will combine into one post-split share."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-077591","json":"https://secwatch.observer/filing/0001213900-26-077591.json","markdown":"https://secwatch.observer/filing/0001213900-26-077591.md","text":"https://secwatch.observer/filing/0001213900-26-077591.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1894525/000121390026077591/0001213900-26-077591-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1894525/000121390026077591/ea0297843-8k_apimeds.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-13T20:32:10.109497+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}